Company: IOBT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058699
Chunk: 18

Company: IO Biotech, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 18
---
 considering the additional factors relevant to the independence of compensation committee members under the applicable standards of the SEC and Nasdaq, and is a “non-employee director” as defined in Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The compensation committee may form and delegate authority to subcommittees consisting of one or more members when it deems appropriate.

Nominating and Corporate Governance Committee

Our board of directors has established a nominating and corporate governance committee and adopted a nominating and corporate governance committee charter. Specific responsibilities of our nominating and corporate governance committee include:

identifying and evaluating candidates to serve on our board of directors, including the nomination of incumbent directors for reelection and nominees recommended by stockholders;

considering and making recommendations to our board of directors regarding changes to the size and composition of our board of directors;

considering and making recommendations to our board of directors regarding the composition and chairmanship of the committees of our board of directors;

instituting plans or programs for the continuing education of our board of directors and orientation of new directors;

establishing procedures to exercise oversight of, and oversee the performance evaluation process of, our board of directors and management;

developing and making recommendations to our board of directors regarding our Corporate Governance Guidelines and other governance matters, including emerging topics such as human capital analysis and disclosures and the Company’s environmental, sustainability and governance (ESG) efforts, progress and disclosures; and

overseeing periodic evaluations of the board of directors’ performance, including committees of the board of directors.

Each of the members of our nominating and corporate governance committee is an independent director under the applicable rules and regulations of Nasdaq relating to nominating and corporate governance committee independence.

<div align='center'>13</div>

Compensation Committee Interlocks and Insider Participation

During the year ended December 31, 2024, none of the members of our compensation committee has, at any time, been one of our officers or employees. None of our executive officers currently serves, or in the past fiscal year has served, as a member of the board of directors or compensation committee (or other committee of the board of directors performing equivalent functions or, in the absence of any such committee, the entire board of directors) of any entity that has one or more executive officers on our board of directors or compensation committee.

Board Membership Criteria and Nomination Process

The board of directors and the nominating and corporate governance committee will determine the appropriate characteristics, skills and experience